Investor Relations. News · Presentations · Stock Information · Analyst Coverage · SEC Filings · Corporate Governance · Annual Meeting and Proxy materials ...
How can I obtain Diffusion Pharmaceuticals' investor relations materials? How can I ... How can I obtain Diffusion Pharmaceuticals' investor relations materials?
CHARLOTTESVILLE, Va., November 14, 2022—Diffusion Pharmaceuticals Inc. (NASDAQ: DFFN) (“Diffusion ... investor relations section of Diffusion's website, investors ...
Diffusion Pharmaceuticals Inc. is an innovative biotechnology company developing new treatments that improve the body's ability to deliver oxygen to the ...
Missing: investor relations
... DFFN, NASDAQ Capital Market. Indicate by check mark whether the registrant is ... investor relations section of Diffusion's website, investors.diffusionpharma.com ...
Investor Contacts: David Kalergis, CEO. Diffusion Pharmaceuticals Inc. (434) 220-0718. dkalergis@diffusionpharma.com. LHA Investor Relations. Kim Sutton ...
Dec 5, 2022 · Investors and stockholders will be able to obtain a copy of the definitive Proxy Statement and other relevant documents filed by Diffusion with ...
People also ask
Is Diffusion Pharmaceuticals a good buy?
Diffusion Pharmaceuticals Inc (US:DFFN) has 0 institutional owners and shareholders ... Investor, Type, Avg ... Presentation at CTAD 2023 Highlighting Learnings ...
Learn how to use EDGAR to research public filings by public companies, mutual funds, ETFs, some annuities, and more. Before you Invest, Investor.gov. Get ...
Check out our DFFN stock analysis, current DFFN quote, charts, and historical prices for Diffusion Pharmaceuticals Inc stock.